Author

Stephanie N. Fox

University of Alabama at BirminghamORCID 0000-0003-2170-8342Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Neuroscience· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:benchmarking· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1

Frequent Co-Authors

Andrew E. ArrantiD· 1 shared Charles MurchisoniD· 1 shared Erik D. RobersoniD· 1 shared Katherine I. WilsoniD· 1 shared Robert V. FareseiD· 1 shared Shreya N. KashyapiD· 1 shared Tobias C. WaltheriD· 1 shared Yohannes Abere AmbawiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperNeuroscience

Andrew E. ArrantORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Carboxy-terminal blockade of sortilin binding enhances progranulin gene therapy, a potential treatment for frontotemporal dementia

Shreya N. Kashyap, Stephanie N. Fox, Katherine I. Wilson, Charles Murchison, Yohannes Abere Ambaw, Tobias C. Walther, Robert V. Farese, Andrew E. Arrant, Erik D. Roberson

Blocking the carboxy terminus of progranulin enhances gene therapy efficacy in progranulin-deficient mice by reducing sortilin interactions and improving biomarker outcomes.

bioRxiv · Sep 15, 2024 · PreprintNeuroscience